Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTUITIVE SURGICAL INCISRG · Entity 2878 | EVP & Chief Operating Officer | December 02, 2019 | December 03, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTUITIVE SURGICAL INC
Report date December 02, 2019 · Filed December 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,143 |
Ending reported balance
After 2019-12-02 transaction · row 17
17 source rows · reconciled sequenceRow 1 · 2019-12-02 · Exercise / conversion · Acquired 843 · Balance 6,214 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. Row 2 · 2019-12-02 · Sale · Disposed 843 · Balance 5,371 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F2: The average selling price for the transactions was $586.686174. The shares sold at: $583.69- $584.7 = 800 shares; $584.00- $585.94 = 900 shares;$585.94- $587= 1302 shares; $587.14 - $588.04 = 570 shares; and $590.00 - $590.34 = 850 shares. Row 3 · 2019-12-02 · Exercise / conversion · Acquired 844 · Balance 6,215 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. Row 4 · 2019-12-02 · Sale · Disposed 844 · Balance 5,371 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F2: The average selling price for the transactions was $586.686174. The shares sold at: $583.69- $584.7 = 800 shares; $584.00- $585.94 = 900 shares;$585.94- $587= 1302 shares; $587.14 - $588.04 = 570 shares; and $590.00 - $590.34 = 850 shares. Row 5 · 2019-12-02 · Exercise / conversion · Acquired 2,735 · Balance 8,106 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. Row 6 · 2019-12-02 · Sale · Disposed 2,735 · Balance 5,371 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F2: The average selling price for the transactions was $586.686174. The shares sold at: $583.69- $584.7 = 800 shares; $584.00- $585.94 = 900 shares;$585.94- $587= 1302 shares; $587.14 - $588.04 = 570 shares; and $590.00 - $590.34 = 850 shares. Row 7 · 2019-12-02 · Exercise / conversion · Acquired 2,734 · Balance 8,105 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. Row 8 · 2019-12-02 · Sale · Disposed 2,734 · Balance 5,371 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F3: The average selling price for the transactions was $586.656974. The shares sold at $583.7-$584.7 = 1,013; shares sold at 548.9-$585.09 = 500; shares sold at $585.12 - $586.04 = 1,336; shares sold at $586.15 - $587.14 = 1,614; shares sold at $587.18 - $588.23 = 1,405; shares sold at $590 - $590.395 = 850. Row 9 · 2019-12-02 · Exercise / conversion · Acquired 2,812 · Balance 8,183 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. Row 10 · 2019-12-02 · Sale · Disposed 2,812 · Balance 5,371 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F3: The average selling price for the transactions was $586.656974. The shares sold at $583.7-$584.7 = 1,013; shares sold at 548.9-$585.09 = 500; shares sold at $585.12 - $586.04 = 1,336; shares sold at $586.15 - $587.14 = 1,614; shares sold at $587.18 - $588.23 = 1,405; shares sold at $590 - $590.395 = 850. Row 11 · 2019-12-02 · Exercise / conversion · Acquired 563 · Balance 5,934 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. Row 12 · 2019-12-02 · Sale · Disposed 563 · Balance 5,371 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F3: The average selling price for the transactions was $586.656974. The shares sold at $583.7-$584.7 = 1,013; shares sold at 548.9-$585.09 = 500; shares sold at $585.12 - $586.04 = 1,336; shares sold at $586.15 - $587.14 = 1,614; shares sold at $587.18 - $588.23 = 1,405; shares sold at $590 - $590.395 = 850. Row 13 · 2019-12-02 · Exercise / conversion · Acquired 305 · Balance 5,676 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. Row 14 · 2019-12-02 · Sale · Disposed 305 · Balance 5,371 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F3: The average selling price for the transactions was $586.656974. The shares sold at $583.7-$584.7 = 1,013; shares sold at 548.9-$585.09 = 500; shares sold at $585.12 - $586.04 = 1,336; shares sold at $586.15 - $587.14 = 1,614; shares sold at $587.18 - $588.23 = 1,405; shares sold at $590 - $590.395 = 850. Row 15 · 2019-12-02 · Exercise / conversion · Acquired 304 · Balance 5,675 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. Row 16 · 2019-12-02 · Sale · Disposed 304 · Balance 5,371 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F3: The average selling price for the transactions was $586.656974. The shares sold at $583.7-$584.7 = 1,013; shares sold at 548.9-$585.09 = 500; shares sold at $585.12 - $586.04 = 1,336; shares sold at $586.15 - $587.14 = 1,614; shares sold at $587.18 - $588.23 = 1,405; shares sold at $590 - $590.395 = 850. Row 17 · 2019-12-02 · Sale · Disposed 1,228 · Balance 4,143 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $178.39 · Expires 2026-02-16 | Direct | 305 |
Reported balance
After 2019-12-02 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2019-12-02 · Exercise / conversion · Disposed 304 · Balance 305 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F4: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $231.00 · Expires 2026-08-15 | Direct | 305 |
Reported balance
After 2019-12-02 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2019-12-02 · Exercise / conversion · Disposed 305 · Balance 305 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F5: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $238.91 · Expires 2027-02-15 | Direct | 2,811 |
Reported balance
After 2019-12-02 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2019-12-02 · Exercise / conversion · Disposed 563 · Balance 2,811 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F4: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $328.46 · Expires 2027-08-15 | Direct | 2,812 |
Reported balance
After 2019-12-02 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2019-12-02 · Exercise / conversion · Disposed 2,812 · Balance 2,812 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F5: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $418.56 · Expires 2028-02-15 | Direct | 3,516 |
Reported balance
After 2019-12-02 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2019-12-02 · Exercise / conversion · Disposed 2,734 · Balance 3,516 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F4: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $499.87 · Expires 2029-08-15 | Direct | 3,656 |
Reported balance
After 2019-12-02 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2019-12-02 · Exercise / conversion · Disposed 844 · Balance 3,656 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F5: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $522.77 · Expires 2028-08-15 | Direct | 3,515 |
Reported balance
After 2019-12-02 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2019-12-02 · Exercise / conversion · Disposed 2,735 · Balance 3,515 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F5: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $548.50 · Expires 2029-02-15 | Direct | 3,657 |
Reported balance
After 2019-12-02 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2019-12-02 · Exercise / conversion · Disposed 843 · Balance 3,657 F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020. F4: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 9, 2020.
F2: The average selling price for the transactions was $586.686174. The shares sold at: $583.69- $584.7 = 800 shares; $584.00- $585.94 = 900 shares;$585.94- $587= 1302 shares; $587.14 - $588.04 = 570 shares; and $590.00 - $590.34 = 850 shares.
F3: The average selling price for the transactions was $586.656974. The shares sold at $583.7-$584.7 = 1,013; shares sold at 548.9-$585.09 = 500; shares sold at $585.12 - $586.04 = 1,336; shares sold at $586.15 - $587.14 = 1,614; shares sold at $587.18 - $588.23 = 1,405; shares sold at $590 - $590.395 = 850.
F4: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F5: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,167 | $0.00 Strike: $303.27 | $0.00 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · derivative · entry 11 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 9,167 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2000 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,250 | $0.00 Strike: $107.27 | $0.00 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · derivative · entry 10 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 Underlying: Common Stock · 1,250 shares Expires 2019-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2000 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 3,000 | $424.67 | $1,274,010.00 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · nonDerivative · entry 8 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456 F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. Read SEC document |
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 3,000 | $341.19 | $1,023,570.00 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · nonDerivative · entry 7 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. Read SEC document |
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 7,656 | $424.67 | $3,251,273.52 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · nonDerivative · entry 6 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456 F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. Read SEC document |
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 7,656 | $334.30 | $2,559,400.80 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · nonDerivative · entry 5 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. Read SEC document |
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 1,250 | $424.67 | $530,837.50 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · nonDerivative · entry 4 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456 F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. Read SEC document |
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 1,250 | $107.27 | $134,087.50 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · nonDerivative · entry 3 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. Read SEC document |
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 9,167 | $424.67 | $3,892,949.89 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · nonDerivative · entry 2 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456 F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. Read SEC document |
| December 01, 2011 Filed Dec 2, 2011 23:34 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 9,167 | $303.27 | $2,780,076.09 |
DisclosureSEC source: 0001035267-11-000026 · edgardoc.xml · nonDerivative · entry 1 Brogna Salvatore · CIK 0001519413 · SVP Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These options were exercised and the underlying shares sold pursuant to a 10b5-1 trading plan adopted by the reporing person on June 15, 2011. Read SEC document |
| July 29, 2011 Filed Aug 1, 2011 21:26 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | OtherCommon Stock | 25 | $274.47 | $6,861.84 |
DisclosureSEC source: 0001035267-11-000011 · edgardoc.xml · nonDerivative · entry 1 Brogna Salvatore · CIK 0001519413 · SVP Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456 F1 · balance_after: The shares beneficially owned increasedd due to a qualified ESPP purchase that took place on 7/29/11. The purchase of these shares is being reported on a voluntary basis. Read SEC document |
| April 28, 2011 Filed Apr 28, 2011 20:18 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 400 | $355.18 | $142,071.20 |
DisclosureSEC source: 0001252986-11-000051 · edgardoc.xml · nonDerivative · entry 3 Brogna Salvatore · CIK 0001519413 · SVP Engineering 10b5-1 filing: Not disclosed Ownership: Indirect · by Father Disclosed balance after: 600 Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 20:18 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,750 | $0.00 Strike: $107.27 | $0.00 |
DisclosureSEC source: 0001252986-11-000051 · edgardoc.xml · derivative · entry 4 Brogna Salvatore · CIK 0001519413 · SVP Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,417 Underlying: Common Stock · 3,750 shares Expires 2019-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2000 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 20:18 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | SaleCommon Stock | 3,750 | $352.29 | $1,321,100.25 |
DisclosureSEC source: 0001252986-11-000051 · edgardoc.xml · nonDerivative · entry 2 Brogna Salvatore · CIK 0001519413 · SVP Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 Read SEC document |
| April 26, 2011 Filed Apr 28, 2011 20:18 UTC | INTUITIVE SURGICAL INC ISRG · Entity 2878 | Exercise / conversionCommon Stock | 3,750 | $107.27 | $402,262.50 |
DisclosureSEC source: 0001252986-11-000051 · edgardoc.xml · nonDerivative · entry 1 Brogna Salvatore · CIK 0001519413 · SVP Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.